125 related articles for article (PubMed ID: 29390354)
1. Common genetic variants in the FETUB locus, genetically predicted fetuin-B levels, and risk of insulin resistance in obese Chinese adults.
Li Z; Liu C; Shi X; Chen Z; Wang D; Li L; Tu Y; Lin M; Liu S; Yang S; Li X
Medicine (Baltimore); 2017 Dec; 96(50):e9234. PubMed ID: 29390354
[TBL] [Abstract][Full Text] [Related]
2. The rs4686434 variant in the fetuin B (FETUB) locus is associated with intrahepatic triglyceride content in obese Chinese adults.
Li Z; Lin M; Liu C; Chen Z; Wang D; Shi X; Yang S; Li XJ
J Diabetes; 2018 Dec; 10(12):916-925. PubMed ID: 29671945
[TBL] [Abstract][Full Text] [Related]
3. Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults.
Li Z; He C; Liu Y; Wang D; Lin M; Liu C; Shi X; Chen Z; Li X; Yang S; Li W
J Atheroscler Thromb; 2020 May; 27(5):418-428. PubMed ID: 31527322
[TBL] [Abstract][Full Text] [Related]
4. Serum fetuin-B is positively associated with intrahepatic triglyceride content and increases the risk of insulin resistance in obese Chinese adults: A cross-sectional study.
Wang D; Liu Y; Liu S; Lin L; Liu C; Shi X; Chen Z; Lin M; Yang S; Li Z; Li X
J Diabetes; 2018 Jul; 10(7):581-588. PubMed ID: 29194974
[TBL] [Abstract][Full Text] [Related]
5. Fetuin-A and risk of coronary heart disease: A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies.
Laugsand LE; Ix JH; Bartz TM; Djousse L; Kizer JR; Tracy RP; Dehghan A; Rexrode K; Lopez OL; Rimm EB; Siscovick DS; O'Donnell CJ; Newman A; Mukamal KJ; Jensen MK
Atherosclerosis; 2015 Nov; 243(1):44-52. PubMed ID: 26343871
[TBL] [Abstract][Full Text] [Related]
6. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the liver-derived plasma protein fetuin-B mediates reversible female infertility.
Floehr J; Dietzel E; Schmitz C; Chappell A; Jahnen-Dechent W
Mol Hum Reprod; 2017 Jan; 23(1):34-44. PubMed ID: 27733488
[TBL] [Abstract][Full Text] [Related]
8. Fetuin-A as an Alternative Marker for Insulin Resistance and Cardiovascular Risk in Prepubertal Children.
Shim YS; Kang MJ; Oh YJ; Baek JW; Yang S; Hwang IT
J Atheroscler Thromb; 2017 Oct; 24(10):1031-1038. PubMed ID: 28154244
[TBL] [Abstract][Full Text] [Related]
9. Hepatokine Fetuin B expression is regulated by leptin-STAT3 signalling and associated with leptin in obesity.
Wang D; Wu M; Zhang X; Li L; Lin M; Shi X; Zhao Y; Huang C; Li X
Sci Rep; 2022 Jul; 12(1):12869. PubMed ID: 35896788
[TBL] [Abstract][Full Text] [Related]
10. Elevated Circulating Fetuin-B Levels Are Associated with Insulin Resistance and Reduced by GLP-1RA in Newly Diagnosed PCOS Women.
Mokou M; Yang S; Zhan B; Geng S; Li K; Yang M; Yang G; Deng W; Liu H; Liu D; Zhu Z; Li L
Mediators Inflamm; 2020; 2020():2483435. PubMed ID: 33061822
[TBL] [Abstract][Full Text] [Related]
11. Fetuin-B Links Nonalcoholic Fatty Liver Disease to Chronic Kidney Disease in Obese Chinese Adults: A Cross-Sectional Study.
Lin M; Liu C; Liu Y; Wang D; Zheng C; Shi X; Chen Z; Liu J; Li X; Yang S; Li Z
Ann Nutr Metab; 2019; 74(4):287-295. PubMed ID: 30965331
[TBL] [Abstract][Full Text] [Related]
12. Fetuin-A and its genetic association with cardiometabolic disease.
Al Ali L; van de Vegte YJ; Said MA; Groot HE; Hendriks T; Yeung MW; Lipsic E; van der Harst P
Sci Rep; 2023 Dec; 13(1):21469. PubMed ID: 38052855
[TBL] [Abstract][Full Text] [Related]
13. Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis.
Kröger J; Meidtner K; Stefan N; Guevara M; Kerrison ND; Ardanaz E; Aune D; Boeing H; Dorronsoro M; Dow C; Fagherazzi G; Franks PW; Freisling H; Gunter MJ; Huerta JM; Kaaks R; Key TJ; Khaw KT; Krogh V; Kühn T; Mancini FR; Mattiello A; Nilsson PM; Olsen A; Overvad K; Palli D; Quirós JR; Rolandsson O; Sacerdote C; Sala N; Salamanca-Fernández E; Sluijs I; Spijkerman AMW; Tjonneland A; Tsilidis KK; Tumino R; van der Schouw YT; Forouhi NG; Sharp SJ; Langenberg C; Riboli E; Schulze MB; Wareham NJ
Diabetes; 2018 Jun; 67(6):1200-1205. PubMed ID: 29523632
[TBL] [Abstract][Full Text] [Related]
14. Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.
Jung SY; Mancuso N; Papp J; Sobel E; Zhang ZF
PLoS One; 2019; 14(6):e0218917. PubMed ID: 31246991
[TBL] [Abstract][Full Text] [Related]
15. Association analysis indicates that a variant GATA-binding site in the PIK3CB promoter is a Cis-acting expression quantitative trait locus for this gene and attenuates insulin resistance in obese children.
Le Stunff C; Dechartres A; Mariot V; Lotton C; Trainor C; Miraglia Del Giudice E; Meyre D; Bieche I; Laurendeau I; Froguel P; Zelenika D; Fallin D; Lathrop M; Roméo PH; Bougnères P
Diabetes; 2008 Feb; 57(2):494-502. PubMed ID: 17977952
[TBL] [Abstract][Full Text] [Related]
16. Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study.
Jensen MK; Bartz TM; Djoussé L; Kizer JR; Zieman SJ; Rimm EB; Siscovick DS; Psaty BM; Ix JH; Mukamal KJ
Diabetes Care; 2013 Oct; 36(10):3121-7. PubMed ID: 23801724
[TBL] [Abstract][Full Text] [Related]
17. Hepatokines Fetuin-A and Fetuin-B status in obese Saudi patient with diabetes mellitus type 2.
Almarashda O; Abdi S; Yakout S; Khattak MNK; Al-Daghri NM
Am J Transl Res; 2022; 14(5):3292-3302. PubMed ID: 35702137
[TBL] [Abstract][Full Text] [Related]
18. Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes.
Yaghootkar H; Lamina C; Scott RA; Dastani Z; Hivert MF; Warren LL; Stancáková A; Buxbaum SG; Lyytikäinen LP; Henneman P; Wu Y; Cheung CY; Pankow JS; Jackson AU; Gustafsson S; Zhao JH; Ballantyne CM; Xie W; Bergman RN; Boehnke M; el Bouazzaoui F; Collins FS; Dunn SH; Dupuis J; Forouhi NG; Gillson C; Hattersley AT; Hong J; Kähönen M; Kuusisto J; Kedenko L; Kronenberg F; Doria A; Assimes TL; Ferrannini E; Hansen T; Hao K; Häring H; Knowles JW; Lindgren CM; Nolan JJ; Paananen J; Pedersen O; Quertermous T; Smith U; ; ; Lehtimäki T; Liu CT; Loos RJ; McCarthy MI; Morris AD; Vasan RS; Spector TD; Teslovich TM; Tuomilehto J; van Dijk KW; Viikari JS; Zhu N; Langenberg C; Ingelsson E; Semple RK; Sinaiko AR; Palmer CN; Walker M; Lam KS; Paulweber B; Mohlke KL; van Duijn C; Raitakari OT; Bidulescu A; Wareham NJ; Laakso M; Waterworth DM; Lawlor DA; Meigs JB; Richards JB; Frayling TM
Diabetes; 2013 Oct; 62(10):3589-98. PubMed ID: 23835345
[TBL] [Abstract][Full Text] [Related]
19. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
Mackawy AM
Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
[TBL] [Abstract][Full Text] [Related]
20. Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance.
De Silva NM; Freathy RM; Palmer TM; Donnelly LA; Luan J; Gaunt T; Langenberg C; Weedon MN; Shields B; Knight BA; Ward KJ; Sandhu MS; Harbord RM; McCarthy MI; Smith GD; Ebrahim S; Hattersley AT; Wareham N; Lawlor DA; Morris AD; Palmer CN; Frayling TM
Diabetes; 2011 Mar; 60(3):1008-18. PubMed ID: 21282362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
